123 related articles for article (PubMed ID: 24936103)
1. A comparison of the tolerability of two dilution volumes (0.5 mL and 1.0 mL) of a purified chick embryo cell rabies vaccine administered intramuscularly to healthy adult volunteers: A randomized, intraindividual, assessor-blind study.
Kulkarni R; Thatte U; Shinde V; Dharadhar S; Popova O; Vakil H
Curr Ther Res Clin Exp; 2004 Jan; 65(1):47-56. PubMed ID: 24936103
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new five-injection, two-site,intradermal schedule for purified chick embryo cell rabies vaccine: A randomized, open-label, active-controlled trial in healthy adult volunteers in India.
Sudarshan MK; Madhusudana SN; Mahendra BJ; Ashwath Narayana DH; Ananda Giri MS; Popova O; Vakil HB
Curr Ther Res Clin Exp; 2005 Jul; 66(4):323-34. PubMed ID: 24672132
[TBL] [Abstract][Full Text] [Related]
3. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV).
Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C
Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
[TBL] [Abstract][Full Text] [Related]
5. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
[TBL] [Abstract][Full Text] [Related]
6. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical study.
Sampath G; Banzhoff A; Deshpande A; Malerczyk C; Arora AK; Vakil H; Preiss S
Hum Vaccin Immunother; 2017 Jul; 13(7):1531-1538. PubMed ID: 28406752
[TBL] [Abstract][Full Text] [Related]
8. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
[TBL] [Abstract][Full Text] [Related]
9. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML.
Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C
Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity study of a new purified chick embryo cell rabies vaccine Vaxirab-N (Pitman-Moore strain) manufactured in India.
Ashwath Narayana DH; Madhusudana SN; Sampath G; Tripathy RM; Sudarshan MK; Gangaboraiah ; Ravish HS; Satapathy DM; Gowda G; Holla R; Ashwin BY; Padhi A; Manjula S; Patel PM
Hum Vaccin Immunother; 2014; 10(1):120-5. PubMed ID: 24030586
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure prophylaxis (PEP) for rabies with purified chick embryo cell vaccine: a systematic literature review and meta-analysis.
Preiss S; Chanthavanich P; Chen LH; Marano C; Buchy P; van Hoorn R; Vonk Noordegraaf M; Mukherjee P
Expert Rev Vaccines; 2018 Jun; 17(6):525-545. PubMed ID: 29939085
[TBL] [Abstract][Full Text] [Related]
12. One-year immunogenicity kinetics and safety of a purified chick embryo cell rabies vaccine and an inactivated Vero cell-derived Japanese encephalitis vaccine administered concomitantly according to a new, 1-week, accelerated primary series.
Cramer JP; Jelinek T; Paulke-Korinek M; Reisinger EC; Dieckmann S; Alberer M; Bühler S; Bosse D; Meyer S; Fragapane E; Costantini M; Pellegrini M; Lattanzi M; Dovali C
J Travel Med; 2016 Mar; 23(3):. PubMed ID: 26994987
[TBL] [Abstract][Full Text] [Related]
13. A Comparative Study on the Adverse Reactions of Purified Chick Embryo Cell Vaccine (PCECV) and Purified Vero Cell Rabies Vaccine (PVRV).
Ramezankhani R; Shirzadi MR; Ramezankhani A; Poor Mozafary J
Arch Iran Med; 2016 Jul; 19(7):502-7. PubMed ID: 27362245
[TBL] [Abstract][Full Text] [Related]
14. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine.
Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C
Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine.
Deshpande AK; Londhe VA; Akarte S; Briggs D
J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031
[TBL] [Abstract][Full Text] [Related]
16. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe.
Kamoltham T; Thinyounyong W; Phongchamnaphai P; Phraisuwan P; Khawplod P; Banzhoff A; Malerczyk C
J Pediatr; 2007 Aug; 151(2):173-7. PubMed ID: 17643772
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India.
Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS
Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446
[TBL] [Abstract][Full Text] [Related]
18. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults.
Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228
[TBL] [Abstract][Full Text] [Related]
19. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups.
Fang Y; Chen L; Liu MQ; Zhu ZG; Zhu ZR; Hu Q
PLoS Negl Trop Dis; 2014 Dec; 8(12):e3412. PubMed ID: 25522244
[TBL] [Abstract][Full Text] [Related]
20. Rabies neutralizing antibody after 2 intradermal doses on days 0 and 21 for pre-exposure prophylaxis.
Wongsaroj P; Udomchaisakul P; Tepsumethanon S; Khawplod P; Tantawichien T
Vaccine; 2013 Mar; 31(13):1748-51. PubMed ID: 23370149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
